Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: Implication of JNK pathway

Biochemical and Biophysical Research Communications

Volumn 393, Issue 2, 2010, Pages 280-285

  Ryu, Joohyun ^a,c   Cho, Sayeon ^b   Park, Byoung Chul ^c   Lee, Do Hee ^d  

^a Kongju National University   (South Korea)

^b Chung Ang University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Seoul Women University   (South Korea)

Author keywords

ASK1; Ataxin 1; JNK; Oxidative stress; Polyglutamine diseases; SUMO 1

Indexed keywords

ACETYLCYSTEINE; APOPTOSIS SIGNAL REGULATING KINASE 1; ATAXIN 1; HYDROGEN PEROXIDE; PROTEIN UBC9; STRESS ACTIVATED PROTEIN KINASE; SUMO 1 PROTEIN;

ARTICLE; CELL FRACTIONATION; CONJUGATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SUMOYLATION;

CELL LINE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OXIDATIVE STRESS; SPINOCEREBELLAR ATAXIAS; SUMO-1 PROTEIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 77649184659     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.122     Document Type: Article

References (33)

1. Paulson H.L., Bonini N.M., and Roth K.A. Polyglutamine disease and neuronal cell death. Proc. Natl. Acad. Sci. USA 97 (2000) 12957-12958
2. Orr H.T., and Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30 (2007) 575-621
3. Shao J., and Diamond M.I. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 16 (2007) R115-R123
4. Williams A.J., and Paulson H.L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 31 (2008) 521-528
5. Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., Zoghbi H.Y., and Orr H.T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95 (1998) 41-53
6. Kang S., and Hong S. Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Mol. Cells 27 (2009) 621-627
7. Tsuda H., Jafar-Nejad H., Patel A.J., Sun Y., Chen H.K., Rose M.F., Venken K.J., Botas J., Orr H.T., Bellen H.J., and Zoghbi H.Y. The AXH domain of ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell 26 (2005) 633-644
8. Chan H.Y., Warrick J.M., Andriola I., Merry D., and Bonini N.M. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11 (2002) 2895-2904
9. Terashima T., Kawai H., Fujitani M., Maeda K., and Yasuda H. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death. Neuroreport 13 (2002) 2359-2364
10. Riley B.E., Zoghbi H.Y., and Orr H.T. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal. J. Biol. Chem. 280 (2005) 21942-21948
11. Tempe D., Piechaczyk M., and Bossis G. SUMO under stress. Biochem. Soc. Trans. 36 (2008) 874-878
12. Kim S.J., Kim T.-S., Hong S., Rhim H., Kim I.Y., and Kang S. Oxidative stimuli affect polyglutamine aggregation and cell death in human mutant ataxin-1-expressing cells. Neurosci. Lett. 348 (2003) 21-24
13. Choi J.Y., Ryu J.H., Kim H.S., Park S.G., Bae K.H., Kang S., Myung P.K., Cho S., Park B.C., and Lee D.H. Co-chaperone CHIP promotes aggregation of ataxin-1. Mol. Cell. Neurosci. 34 (2007) 69-79
14. Lee J.A., Park J.E., Lee D.H., Park S.G., Myung P.K., Park B.C., and Cho S. G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1. Oncogene 27 (2008) 1297-1305
15. Kim K.I., Baek S.H., and Chung C.H. Versatile protein tag, SUMO: its enzymology and biological function. J. Cell. Physiol. 191 (2002) 257-268
16. Lin D., Tatham M.H., Yu B., Kim S., Hay R.T., and Chen Y. Identification of a substrate recognition site on Ubc9. J. Biol. Chem. 277 (2002) 21740-21748
17. Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., and Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38 (2003) 375-387
18. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M.C., Orr H.T., Botas J., and Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113 (2003) 457-468
19. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192 (2002) 1-15
20. Cowan K.J., Diamond M.I., and Welch W.J. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum. Mol. Genet. 12 (2003) 1377-1391
21. Merienne K., Helmlinger D., Perkin G.R., Devys D., and Trottier Y. Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway. J. Biol. Chem. 278 (2003) 16957-16967
22. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.-C., Luchak J.-M., Martinez P., Turiegano E., et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408 (2000) 101-106
23. Meriin A.B., Mabuchi K., Gabai V.L., Yaglom J.A., Kazantsev A., and Sherman M.Y. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J. Cell Biol. 153 (2001) 851-864
24. Lyst M.J., and Stancheva I. A role for SUMO modification in transcriptional repression and activation. Biochem. Soc. Trans. 35 (2007) 1389-1392
25. Mukherjee S., Thomas M., Dadgar N., Lieberman A.P., and Iniguez-Lluhí J.A. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J. Biol. Chem. 284 (2009) 21296-21306
26. Janer A., Werner A., Takahashi-Fujigasaki J., Daret A., Fujigasaki H., Takada K., Duyckaerts C., Brice A., Dejean A., and Sittler A. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Hum. Mol. Genet. 19 (2010) 181-195
27. Verger A., Perdomo J., and Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4 (2003) 137-142
28. Guo B., Yang S.-H., Witty J., and Sharrocks A.D. Signalling pathways and the regulation of SUMO modification. Biochem. Soc. Trans. 35 (2007) 1414-1418
29. Yang S.-H., Jaffray E., Hay R.T., and Sharrocks A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12 (2003) 63-74
30. Ohshima T., and Shimotohno K. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J. Biol. Chem. 278 (2003) 50833-50842
31. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., and Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16 (2002) 1345-1355
32. Cho K.J., Lee B.I., Cheon S.Y., Kim H.W., Kim H.J., and Kim G.W. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington Disease. Neuroscience 163 (2009) 1128-1134
33. de Chiara C., Menon R.P., Strom M., Gibson T.J., and Pastore A. Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors. PLoS ONE 4 (2009) e8372